Valneva SE (VALN) Times Interest Earned (2021 - 2026)
Valneva SE (VALN) posted quarterly Times Interest Earned of $4.65 for Q1 2026, up 366.84% year-on-year from $1.0 in Q1 2025, and up 507.18% on a QoQ basis from -$1.14 in Q4 2025.
Valneva SE (VALN) Times Interest Earned (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Times Interest Earned for 6 consecutive years, with $4.65 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 366.84% year-over-year to $4.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.39 (up 6.16% YoY) and the FY2025 annual result came in at -$1.96, down 452.61% from the prior year.
- Times Interest Earned climbed to $4.65 in Q1 2026 per VALN's latest filing, from -$1.14 in the prior quarter.
- Over the last five years, Times Interest Earned for VALN reached as high as $37.92 in Q2 2022 and fell as low as -$17.96 in Q3 2022.
- A 5-year average of $0.32 and a median of -$1.14 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned plunged 397.68% — and 2026, when it surged 366.84%.
- Year by year, Times Interest Earned stood at -$1.74 in 2022, then soared by 59.94% to -$0.7 in 2023, then plunged by 376.5% to -$3.31 in 2024, then surged by 65.52% to -$1.14 in 2025, then soared by 507.18% to $4.65 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $4.65, -$1.14, and -$6.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 4.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.65 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -6.49 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | -3.31 |
| Sep 30, 2024 | -2.18 |
| Jun 30, 2024 | -1.21 |
| Mar 31, 2024 | -9.68 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | 1.04 |
| Jun 30, 2023 | -1.32 |
| Mar 31, 2023 | 3.25 |
| Dec 31, 2022 | -1.74 |
| Sep 30, 2022 | -17.96 |
| Jun 30, 2022 | 37.92 |
| Mar 31, 2022 | 3.90 |
| Dec 31, 2021 | 7.44 |
| Sep 30, 2021 | -89.23 |
| Jun 30, 2021 | 14.39 |